What is NDC 68382-106?

68382-106 is the product NDC for divalproex sodium, Divalproex sodium 125 mg/1 capsule, coated pellets, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Zydus Pharmaceuticals USA Inc., NDC labeler code 68382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for divalproex sodium?

185 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

divalproex sodium NDC 68382-106 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)68382-106Labeler and product segments. Claims need a package NDC.

Product NDC at billing width68382-0106Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
68382-106-01	6838201060168382010601	100 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-106-01)Marketed from Jan 27, 2009
68382-106-10	6838201061068382010610	1000 CAPSULE, COATED PELLETS in 1 BOTTLE (68382-106-10)Marketed from Jan 27, 2009
68382-106-77	6838201067768382010677	100 BLISTER PACK in 1 CARTON (68382-106-77) / 1 CAPSULE, COATED PELLETS in 1 BLISTER PACK (68382-106-30)Marketed from Jan 27, 2009

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): divalproex sodium
Generic name (nonproprietary): divalproex sodium
Active ingredients: Divalproex sodium — 125 mg/1
Dosage form: Capsule, Coated pellets
Route: Oral
Labeler: Zydus Pharmaceuticals USA Inc.NDC labeler code 68382
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078919
Marketing start: Jan 27, 2009
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 68382-106_3b089c0e-35d2-40ed-a4ad-7c9c32c391beSPL ID 3b089c0e-35d2-40ed-a4ad-7c9c32c391beSPL set ID ed710c62-8ba6-4f19-b240-3ee73cd03d67RxCUI 1099596UNII 644VL95AO6
Pharmacologic class: Anti-epileptic Agent; Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N468382010601 followed by a unit qualifier and the quantity

Package 68382-0106-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 6, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Divalproex sodium delayed-release capsules are an anti-epileptic drug indicated for: Monotherapy and adjunctive therapy of complex partial seizures and simple and complex absence seizures; adjunctive therapy in patients with multiple seizure types that include absence seizures ( 1 ) 1.1 Epilepsy Divalproex sodium delayed-release capsules are indicated as monotherapy and adjunctive therapy in the treatment of adult patients and pediatric patients down to the age of 10 years with complex partial seizures that occur either in isolation or in association with other types of seizures. Divalproex sodium delayed-release capsules are also indicated for use as sole and adjunctive therapy in the treat…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 68382-106

What is NDC 68382-106?: 68382-106 is the product NDC for divalproex sodium, Divalproex sodium 125 mg/1 capsule, coated pellets, listed with the FDA by Zydus Pharmaceuticals USA Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: divalproex sodium.
What is the active ingredient?: Divalproex sodium.
Who is the labeler?: Zydus Pharmaceuticals USA Inc., NDC labeler code 68382. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for divalproex sodium?: 185 other product NDCs are listed under this name. See all divalproex sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other divalproex sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
divalproex sodium	Divalproex sodium 250 mg/1	Tablet, Film coated, Extended releaseOral	Coupler LLC	67046-1696	67046-1696-03
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Cardinal Health 107, LLC	55154-0577	55154-0577-00
divalproex sodium	Divalproex sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-4193	68788-4193-0368788-4193-0668788-4193-09
divalproex sodium	Divalproex sodium 250 mg/1	Tablet, Delayed releaseOral	Coupler LLC	67046-1683	67046-1683-03
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Delayed releaseOral	Unit Dose Solutions, Inc.	87441-027	87441-0027-01
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Delayed releaseOral	Unit Dose Solutions, Inc.	87441-028	87441-0028-01
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Extended releaseOral	Coupler LLC	67046-2021	67046-2021-03
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Extended releaseOral	Preferred Pharmaceuticals Inc.	68788-4100	68788-4100-0368788-4100-0668788-4100-09
Divalproex Sodium	Divalproex sodium 250 mg/1	Tablet, Film coated, Extended releaseOral	Safecor Health, LLC	48433-033	48433-0033-08
Divalproex Sodium	Divalproex sodium 500 mg/1	Tablet, Film coated, Extended releaseOral	Safecor Health, LLC	48433-034	48433-0034-08

All 186 divalproex sodium NDCs

Other NDCs under ANDA 078919

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078919
Product	Strength	Form · route	Labeler	Product NDC
divalproex sodium	Divalproex sodium 125 mg/1	Capsule, Coated pelletsOral	ATLANTIC BIOLOGICALS CORP.	17856-0109
Divalproex Sodium	Divalproex sodium 125 mg/1	Capsule, Coated pelletsOral	Cardinal Health 107, LLC	55154-4759
divalproex sodium	Divalproex sodium 125 mg/1	Capsule, Coated pelletsOral	Zydus Lifesciences Limited	65841-639
Divalproex Sodium	Divalproex sodium 125 mg/1	Capsule, Coated pelletsOral	American Health Packaging	68084-313
divalproex sodium	Divalproex sodium 125 mg/1	Capsule, Coated pelletsOral	REMEDYREPACK INC.	70518-1749